Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 4
Submit an article Journal homepage
71
Views
3
CrossRef citations to date
0
Altmetric
Letter

Successful idiotypic vaccination following stem cell allotransplant in lymphoma

Ascensión López-Díaz de CerioLaboratory of Immunotherapy, Oncology Division, Center for Applied Medical Research, Pamplona, Spain
,
Susana InogésLaboratory of Immunotherapy, Oncology Division, Center for Applied Medical Research, Pamplona, Spain;Immunotherapy Program, Cell Therapy Area, University of Navarra Hospital, Pamplona, Spain
,
Weiyun Z. AiDivision of Hematology, Department of Medicine, University of California, San Francisco, CA, USA
,
Helena VillanuevaLaboratory of Immunotherapy, Oncology Division, Center for Applied Medical Research, Pamplona, Spain
,
Fernando PastorLaboratory of Immunotherapy, Oncology Division, Center for Applied Medical Research, Pamplona, Spain
,
Mario Martínez SoldevillaLaboratory of Immunotherapy, Oncology Division, Center for Applied Medical Research, Pamplona, Spain
,
Elena SoriaLaboratory of Immunotherapy, Oncology Division, Center for Applied Medical Research, Pamplona, Spain
&
Maurizio BendandiLaboratory of Immunotherapy, Oncology Division, Center for Applied Medical Research, Pamplona, Spain;Immunotherapy Program, Cell Therapy Area, University of Navarra Hospital, Pamplona, SpainCorrespondence[email protected]
 show all
Pages 881-884 | Received 19 Jun 2012, Accepted 12 Aug 2012, Published online: 05 Sep 2012

References

  • de Cerio AL, Zabalegui N, Rodríguez-Calvillo M, . Anti-idiotype antibodies in cancer treatment. Oncogene 2007;26:3594–3602.
  • Bendandi M. Aiming at a curative strategy for follicular lymphoma. CA Cancer J Clin 2008;58:305–317.
  • Rodríguez-Calvillo M, Inogés S, López-Díaz de Cerio A, . Variations in “rescuability” of immunoglobulin molecules from different forms of human lymphoma: implications for anti-idiotype vaccine development. Crit Rev Oncol Hematol 2004;52:1–7.
  • Inogès S, Rodrìguez-Calvillo M, Zabalegui N, . Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma. J Natl Cancer Inst 2006;98:1292–1301.
  • Bendandi M, Marillonnet S, Kandzia R, . Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma. Ann Oncol 2010;21:2420–2427.
  • Inoges S, de Cerio AL, Soria E, . Idiotype vaccines for human B-cell malignancies. Curr Pharm Des 2010;16:300–307.
  • Timmerman JM, Vose JM, Czerwinski DK, . Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma. Leuk Lymphoma 2009;50:37–46.
  • Bendandi M, Gocke CD, Kobrin CB, . Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nat Med 1999; 5:1171–1177.
  • Schuster SJ, Neelapu SS, Gause BL, . Vaccination with patient-specific tumour-derived antigen in first remission improves disease-free survival in follicular lymphoma. J Clin Oncol 2011;29:2787–2794.
  • Bendandi M. Idiotype vaccines for lymphoma: proof-of-principles and clinical trial failures. Nat Rev Cancer 2009;9:675–681.
  • Freedman A, Neelapu SS, Nichols C, . Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphoma. J Clin Oncol 2009;27:3036–3043.
  • Kwak LW, Taub DD, Duffey PL, . Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor. Lancet 1995;345:1016–1020.
  • Bendandi M, Rodríguez-Calvillo M, Inogés S, . Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation. Leuk Lymphoma 2006;47:29–37.
  • Inoges S, Lopez-Diaz de Cerio A, Sampol A, . Stem cell transplant and idiotypic vaccination for B-cell malignancies. Curr Top Med Chem 2011;11:1653–1660.
  • Inoges S, Lopez-Diaz de Cerio A, Zabalegui N, . Prolonged idiotypic vaccination against follicular lymphoma. Leuk Lymphoma 2009;50:47–53.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.